CogniSens Adds Top Healthcare Angel to its Board

Richard Holdren, founder of a NASDAQ traded company, brings with him his healthcare expertise and determination to deliver the innovative NeuroTracker technology to the medical market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
NeuroTracker
NeuroTracker is a cutting edge innovation that will revolutionize healthcare

(PRWEB) April 27, 2012

CogniSens Inc. has added Richard Holdren to its board of Directors. Richard is an experienced Angel Investor and serial entrepreneur in the healthcare market, he has been named Center for Entrepreneurship & Innovation Mentor of the year and has investments in over 50 startups. Having also previously been a partner in the nation's largest physician search firm and co-founder of Texas's largest practice management firm, Richard has unparalleled market expertise that will enable CogniSens to transfer its successful performance enhancement technology to the healthcare and rehabilitation industry.

“Rick brings considerable expertise and in-depth understanding of the healthcare market to our board,” says Jean Castonguay, president and CEO of CogniSens Athletics. “Through personal experience he knows how important innovation is in providing effective healthcare, and we are honored to have him onboard as we move into the medical and rehabilitation markets.”

Describing his interests as, “Healthcare early stage technology anywhere in the world,” Richard has been involved in early stage investments for over 30 years and has been instrumental in 4 large scale IPOs, including Equivision, a NASDAQ traded company, and EquiMed which has a market cap of over $200 million.

“Rick has an open mind on investments,” says a previous colleague referring to his focus on medical innovations, he also believes that Richard “is quick to see the investment opportunity and move on it.”

Having recognized the potential of CogniSens Inc.’s technologies, Richard has moved quickly to establish its flagship technology NeuroTracker in the healthcare sector. The technology is already being validated at various medical and rehabilitation institutions, and Richard will continue to use his extensive expertise to drive market penetration for what he believes to be “a cutting edge innovation that will revolutionize healthcare.”

About Cognisens Inc.

A privately-owned company based in Montreal, Canada, CogniSens Inc. specializes in neurobiological science and technology dedicated to improving the full spectrum of human performance. For further information please consult:

http://www.cognisens.com


Contact